echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J Allergy Clin Immunol: Patients with high IL-17 asthma have psoriasis immunotypes.

    J Allergy Clin Immunol: Patients with high IL-17 asthma have psoriasis immunotypes.

    • Last Update: 2020-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The role of IL-17 immunity in patients with inflammatory diseases such as psoriasis and inflammatory bowel disease has been fully recognized, but its role in asthma patients is not obvious and needs further study.
    study, which aims to conduct an in-depth esologic study of asthma patients with il-17 immunity, was published online at J Allergy Clin Immunol.
    A genome-wide transcription group analysis was performed using skin brush tablets, bronchial biopsy specimens (91 asthma patients and 46 healthy control group subjects) and whole blood samples (n s 498) from u-BIOPRED queues that predict respiratory disease outcomes.
    used in-body induced genetic markers of IL-17 and IL-13 in bronchial endotment cells to identify patients with IL-17 high and IL-13 high asthma esoteric.
    results, 22 out of 91 patients and 9 patients were identified with IL-17 and IL-13 gene markers.
    high IL-17 asthma patients are characterized by frequent seizures, increased neutral granulocytes in the air (sputum and mucous membranes), reduced diversity of the lung microbiome, and the risk of urine biomarkers activated by the thrombosis B2 pathway.
    In pathline analysis, genes expressed differently in patients with high IL-17 asthma had something in common with genes that altered skin loss in psoriasis, including genes that regulate the function and defense mechanisms of the endotment barrier, such as IL1B, IL6, IL8, and β-defenses.
    , the results show that the high IL-17 asthma ideotope, characterized by bronchial endocrine dysfunction and an increase in antibacterial and inflammatory responses, is similar to the immunoshapype of psoriasis, including the activation of the thrombosis B2 pathline, and should be considered a biomarker of the ideology in further studies, including clinical trials of IL-17.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.